住院COVID-19成人清醒俯卧位的评估:一项非随机对照试验
这项在2个学术医学中心开展的非随机对照试验纳入501例未接受机械通气的COVID-19相关低氧血症成人,1:1分配至推荐清醒俯卧位干预组或常规治疗组。干预组每日俯卧位中位时间4.2小时(IQR 1.8-6.7),常规组0小时(IQR 0-0.7)。第5天干预组在改良WHO序贯量表上结局更差的后验概率为0.998(aOR 1.63,95%CrI 1.16-2.31);第14天和第28天的危害后验概率分别为0.874(aOR 1.29,95%CrI 0.84-1.99)和0.673(aOR 1.12,95%CrI 0.67-1.86)。探索性结局(进展至机械通气、住院时间、28天死亡率)两组无差异。
要点
- 在未接受机械通气的COVID-19低氧血症成人中,推荐清醒俯卧位组第5天改良WHO序贯量表结局更差的后验概率为0.998(aOR 1.63,95%CrI 1.16-2.31)。
- 第14天危害后验概率为0.874(aOR 1.29,95%CrI 0.84-1.99),第28天为0.673(aOR 1.12,95%CrI 0.67-1.86)。
- 干预组每日俯卧位中位时间4.2小时(IQR 1.8-6.7),常规组0小时(IQR 0-0.7)。
- 进展至机械通气、住院时间和28天死亡率等探索性结局两组无差异。
- 作者认为,清醒俯卧位在未插管COVID-19低氧血症患者中未观察到临床获益,第5天结局恶化提示潜在危害。
适用人群与场景
- 纳入:2020年5月13日至12月11日在2个学术医学中心(Vanderbilt University Medical Center和NorthShore University HealthSystem)住院的501例COVID-19相关低氧血症成人,未接受机械通气。
- 排除:需有创机械通气者(原文按未接受机械通气定义纳入人群)。
处置流程与药物剂量
- 干预组接受执业医师推荐的清醒俯卧位干预;常规组接受常规治疗。
- 干预组每日俯卧位中位时间4.2小时(IQR 1.8-6.7),常规组0小时(IQR 0-0.7)。
研究设计与关键结果
- 研究类型:非随机对照试验,2个学术医学中心,501例未接受机械通气的COVID-19相关低氧血症成人,1:1分配至推荐清醒俯卧位干预组或常规治疗组。
- 人群特征:平均(SD)年龄61.0(15.3)岁;284例(56.7%)男性;417例(83.2%)自报非西班牙裔或非拉丁裔。
- 基线严重度:干预组 vs 常规组,标准低流量鼻导管吸氧170例(65.9%) vs 162例(66.7%);高流量鼻导管吸氧71例(27.5%) vs 62例(25.5%);无创正压通气16例(6.2%) vs 19例(7.8%)。
- 主要终点(第5天改良WHO序贯量表):干预组结局更差的后验概率0.998(后验中位aOR 1.63,95%CrI 1.16-2.31)。
- 第14天危害后验概率0.874(aOR 1.29,95%CrI 0.84-1.99);第28天危害后验概率0.673(aOR 1.12,95%CrI 0.67-1.86)。
- 探索性结局:进展至机械通气、住院时间、28天死亡率两组无差异。
证据类型、等级与局限
- 证据类型:非随机对照试验(pragmatic nonrandomized controlled trial)。
- 局限:原告未报告局限性。
对床旁实践的改变
- 作者认为,在未接受机械通气的COVID-19相关低氧血症患者中,清醒俯卧位未观察到临床获益,且第5天结局恶化提示潜在危害。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Awake prone positioning may improve hypoxemia among patients with COVID-19, but whether it is associated with improved clinical outcomes remains unknown.
OBJECTIVE: To determine whether the recommendation of awake prone positioning is associated with improved outcomes among patients with COVID-19-related hypoxemia who have not received mechanical ventilation.
DESIGN, SETTING, AND PARTICIPANTS: This pragmatic nonrandomized controlled trial was conducted at 2 academic medical centers (Vanderbilt University Medical Center and NorthShore University HealthSystem) during the COVID-19 pandemic. A total of 501 adult patients with COVID-19-associated hypoxemia who had not received mechanical ventilation were enrolled from May 13 to December 11, 2020.
INTERVENTIONS: Patients were assigned 1:1 to receive either the practitioner-recommended awake prone positioning intervention (intervention group) or usual care (usual care group).
MAIN OUTCOMES AND MEASURES: Primary outcome analyses were performed using a bayesian proportional odds model with covariate adjustment for clinical severity ranking based on the World Health Organization ordinal outcome scale, which was modified to highlight the worst level of hypoxemia on study day 5.
RESULTS: A total of 501 patients (mean [SD] age, 61.0 [15.3] years; 284 [56.7%] were male; and most [417 (83.2%)] were self-reported non-Hispanic or non-Latinx) were included. Baseline severity was comparable between the intervention vs usual care groups, with 170 patients (65.9%) vs 162 patients (66.7%) receiving oxygen via standard low-flow nasal cannula, 71 patients (27.5%) vs 62 patients (25.5%) receiving oxygen via high-flow nasal cannula, and 16 patients (6.2%) vs 19 patients (7.8%) receiving noninvasive positive-pressure ventilation. Nursing observations estimated that patients in the intervention group spent a median of 4.2 hours (IQR, 1.8-6.7 hours) in the prone position per day compared with 0 hours (IQR, 0-0.7 hours) per day in the usual care group. On study day 5, the bayesian posterior probability of the intervention group having worse outcomes than the usual care group on the modified World Health Organization ordinal outcome scale was 0.998 (posterior median adjusted odds ratio [aOR], 1.63; 95% credibility interval [CrI], 1.16-2.31). However, on study days 14 and 28, the posterior probabilities of harm were 0.874 (aOR, 1.29; 95% CrI, 0.84-1.99) and 0.673 (aOR, 1.12; 95% CrI, 0.67-1.86), respectively. Exploratory outcomes (progression to mechanical ventilation, length of stay, and 28-day mortality) did not differ between groups.
CONCLUSIONS AND RELEVANCE: In this nonrandomized controlled trial, prone positioning offered no observed clinical benefit among patients with COVID-19-associated hypoxemia who had not received mechanical ventilation. Moreover, there was substantial evidence of worsened clinical outcomes at study day 5 among patients recommended to receive the awake prone positioning intervention, suggesting potential harm.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04359797.
参考来源
- Qian ET, Gatto CL, Amusina O, et al. Assessment of Awake Prone Positioning in Hospitalized Adults With COVID-19: A Nonrandomized Controlled Trial. JAMA Intern Med. 2022. PMID: 35435937. doi:10.1001/jamainternmed.2022.1070
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。